Return-Path: <3480-1954-3508-913-ibd+5Fdoc=jcbl.com@mail.trientsma.trade>
Delivered-To: spam-quarantine
X-Envelope-To: <ibd_doc@jcbl.com>
X-Envelope-To-Blocked: <ibd_doc@jcbl.com>
X-Quarantine-ID: <a6b8qRGrAB78>
X-Spam-Flag: YES
X-Spam-Score: 6.643
X-Spam-Level: ******
X-Spam-Status: Yes, score=6.643 tag=2 tag2=6.31 kill=6.31
	tests=[DKIM_SIGNED=0.1, HTML_MESSAGE=0.001, MIME_HTML_MOSTLY=0.001,
	MPART_ALT_DIFF=0.724, RAZOR2_CF_RANGE_51_100=0.365,
	RAZOR2_CF_RANGE_E8_51_100=2.43, RAZOR2_CHECK=1.729, RDNS_NONE=1.274,
	SPF_PASS=-0.001, T_DKIM_INVALID=0.01, T_REMOTE_IMAGE=0.01]
	autolearn=no
Received: from mx10.jcbl.com ([127.0.0.1])
	by localhost (mx9.jcbl.com [127.0.0.1]) (amavisd-new, port 10024)
	with ESMTP id a6b8qRGrAB78 for <ibd_doc@jcbl.com>;
	Thu, 15 Nov 2018 20:49:15 +0530 (IST)
Received: from dione.trientsma.trade (unknown [185.148.240.5])
	by mx10.jcbl.com (Postfix) with ESMTP id E4D58F4429A
	for <ibd_doc@jcbl.com>; Thu, 15 Nov 2018 20:49:13 +0530 (IST)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=trientsma.trade;
 h=Mime-Version:Content-Type:Date:From:Reply-To:Subject:To:Message-ID; i=Info@trientsma.trade;
 bh=BZISqsj0Ly7MMM3pADBjY1iSJGc=;
 b=QjKVptiHkZIY9vbnab/ORy12/sVpXPK74B2T3MmbNw6ayvgHY5G/mObwa7cU4eBNOBQaKCPWG6qB
   LL2VpJWmE7oWJWGGUIws4wB8HuB3gbfn4nu+qfHL/q/UQx2wA0Lz2xsSRbkFLON6kuJkQloCTLJl
   8k2s94jhiHXsqi8G7YQ=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=trientsma.trade;
 b=H9s+gVBtF2yzxjSWgq911FsHVe6K7XpuHzIk7SzEoO6+g+P3ljKQnrO9T7d0c+2xElsgc5XA7OBA
   aJMEqzgpLuxVaOjM2C3G5ItGv8QxQAjh61q/fs0GhcFn9RI5nuXDrjcmJQmQJGDVh5gGhTX+d7Gc
   +/M9trnG4lYSndrNld8=;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="84a3f4fbe7962bba77a7b5a23e868830"
Date: Thu, 15 Nov 2018 10:11:08 -0500
From: "Underground Fat Loss Manual" <Info@trientsma.trade>
Reply-To: "Underground Fat Loss Manual" <Support@trientsma.trade>
Subject: Amazon banned this fat loss secret?
To: <ibd_doc@jcbl.com>
Message-ID: <nmlpjxhyowwibbzs-7n8g8a1q8y0ezu8a-db4@trientsma.trade>

--84a3f4fbe7962bba77a7b5a23e868830
Content-Type: text/plain;

Content-Transfer-Encoding: 8bit

--84a3f4fbe7962bba77a7b5a23e868830
Content-Type: text/html;
Content-Transfer-Encoding: 8bit

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<title>Untitled Document</title>
</head>
<body><a href="http://trientsma.trade/clk.3508-3480-0-1954-913-1440-de651627-0300"><img border="0" src="http://trientsma.trade/clk.3508-3480-14-1954-913-1440-e0af4891-0300" /> </a>
<table align="center" style="font-size:17px;font-family:Georgia; text-align:justify" width="630">
	<tbody>
		<tr>
			<td><img src="http://trientsma.trade/7aaf326fdd5d9d8a84.png" width="630" /></td>
		</tr>
		<tr>
			<td style="padding:15px">
			<p style="font-size:20px;color:#790000"><b>Fans are raving about <a href="http://trientsma.trade/clk.3508-3480-2-1954-913-1440-9ed947d2-0300" style="color:#790000" target="_blank">this extreme fat loss program...</a></b></p>

			<p style="font-size:19px"><b>... so why is it banned on Amazon?</b></p>

			<p>Thousands of people are using this unconventional method to get lean fast.</p>

			<p><b>Is that why Facebook blacklisted this program?</b></p>

			<p>Is there some reason why even Google doesn&#39;t want this controversial method to see the light of day? Here&rsquo;s the shocking reason why these giant companies are trying to silence this middle-aged personal trainer from Michigan&hellip;</p>

			<p align="center"><a href="http://trientsma.trade/clk.3508-3480-2-1954-913-1440-9ed947d2-0300" style="color:#790000" target="_blank"><b>EXPOSED: Why Did This Extreme Fat Loss Program Get Banned?</b></a></p>

			<p style="font-family:Lucida Handwriting;font-size:15px">Charles Garrett</p>

			<p><b>P.S.</b> Did you know that <b>chewing a baby aspirin</b> can help you lose fat? That&#39;s just one of the controversial tips <a href="http://trientsma.trade/clk.3508-3480-2-1954-913-1440-9ed947d2-0300" target="_blank">revealed here...</a></p>
			</td>
		</tr>
	</tbody>
</table>

<table align="center">
	<tbody>
		<tr>
			<td align="center" style="font-size:10px;">
			<hr /><br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			Remove from our Email List <a href="http://trientsma.trade/clk.3508-3480-12-1954-913-1440-d6997ceb-0300"> press this link </a><br />
			828 Derek Drive Akron, OH 44311</td>
		</tr>
		<tr>
			<td align="left" height="30">&nbsp;</td>
		</tr>
	</tbody>
</table>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; font-size:5px">Asthma experts said that with increased accessibility to OTC options, people may be less likely to communicate symptoms with their medical team and this can have life-threatening consequences. They noted that 22 million people in the United States le with this chronic condition that can require immediate action when it flares up. They mentioned 10 people die from the ailment each day and those deaths are spread evenly among people with mild, moderate, and severe asthma. &ldquo;We know that the No. 1 reason 10 people die from asthma daily is due to lack of control and overuse of quick-relief medication,&rdquo; Winders said. &ldquo;This newly approved product will be used to mask the symptoms of asthma without addressing the underlying cause. Furthermore, it will likely delay access to appropriate care and could undermine the physician-patient relationship as the doctor will have no
  knowledge if patients are using Primatene Mist OTC.&rdquo; Kenneth Mendez, president and chief executive officer at the Asthma and Allergy Foundation of America, shared similar sentiments in an official statement: &ldquo;AAFA supports access to affble treatment options for our community. However, it is unknown how the FDA&rsquo;s approval of Primatene Mist may impact asthma outcomes. It is not currently a guidelines-based treatment. </span>

<p align="center"><span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; font-size:5px"><a href="http://trientsma.trade/clk.3508-3480-20-1954-913-1440-c023b83c-0300"><img src="http://trientsma.trade/69f9f91455dab19bfd.jpg" /></a></span></p>
<span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; font-size:5px"> </span></body>
</html>

--84a3f4fbe7962bba77a7b5a23e868830--

